VIGGS:GBrowse

Vigan.02G134900.01

Basic Information:

Name:	Vigan.02G134900.01 Multiple alignment Variant Information
Position:	Chr02:12069823..12076114 (+ strand)
Length:	6292

Functional Information:

Description:	Similar to Proteasome subunit beta type. [C6SXW4, Glycine max]
GO:	Biological Process: proteolysis involved in cellular protein catabolic process (GO:0051603)
	Cellular Component: proteasome core complex (GO:0005839)
	Molecular Function: endopeptidase activity (GO:0004175)
	Molecular Function: threonine-type endopeptidase activity (GO:0004298)
InterPro:	Proteasome, subunit alpha/beta (IPR001353)
	Proteasome beta-type subunit, conserved site (IPR016050)
	Proteasome B-type subunit (IPR023333)
Expression level (FPKM):	Co,Em,Fl,Le,No,Po,Ro,St:26.36,23.39,39.33,34.87,55.34,72.82,30.39,28.48

Automatic updates:

Name:	NM_001250349 NCBI(nuccore)
Organism:	Glycine max
Description:	Glycine max putative proteasome beta subunit C1 (LOC100306084), mRNA.
PubMed ID:	-
Status:	Known Variant

Structure :

[show][hide]Parts:

Position:	Chr02:12069823..12069937 (+ strand)
Length:	115
Type:	five_prime_UTR

Position:	Chr02:12069938..12070233 (+ strand)
Length:	296
Type:	CDS

Position:	Chr02:12072064..12072153 (+ strand)
Length:	90
Type:	CDS

Position:	Chr02:12072561..12072645 (+ strand)
Length:	85
Type:	CDS

Position:	Chr02:12074836..12074930 (+ strand)
Length:	95
Type:	CDS

Position:	Chr02:12075521..12075569 (+ strand)
Length:	49
Type:	CDS

Position:	Chr02:12075570..12076114 (+ strand)
Length:	545
Type:	three_prime_UTR

[hide all][show all]SEQUENCES

[show][hide][copy]EXON + INTRON

[show][hide][copy]TRANSCRIPT

>Vigan.02G134900.01
TTTATATATT TATTAAATTT AGCACCACGT TAGGGCTTAG TTCCAAACAC TACAGATTTT AGCAAATACC CGTGTATGTG
ACGAAATCAG AAAATTGGTT GATCAGCAGC GAAAGATGTC GATCTTCGAG TACAATGGGA GTGCCCTAGT GGCCATGGTG
GGGAAGAACT GCTTCGCCAT TGCCAGCGAT CGGAGACTCG GGGTTCAGCT CCAGACTATC GCCACCGATT TCCAGAGGAT
TTCCAAGATC CACGACAAGC TTTTCATCGG TCTCTCGGGC CTCGCCACCG ACGCTCAGAC GCTCTACCAG CGCCTCGTTT
TCCGCCACAA ATTGTATCAG CTGCGTGAAG AGAGGGATAT GAAGCCCGAA ACCTTTGCTA GCCTAGTCTC TGCTATTCTC
TACGAGAAAA GGTTTGGTCC ATACTTTTGC CAACCTGTAA TTGCTGGACT AGGAGATGAA GATAAACCTT TCATTTGCAC
CATGGATGCG ATTGGAGCAA AGGAACTTGC AAAAGATTTT GTTGTAGCCG GTACTGCATC TGAGTCTCTT TATGGGGCTT
GCGAGTCAAT GTTTAAGCCT GACATGGAAC CAGAGGAATT GTTCGAGACT ATCTCCCAAG CGCTACAATC ATCTGTCGAT
CGAGATTGTT TAAGTGGCTG GGGTGGACAT GTTTATGTTG TCACCCCAAC CGAAGTAAAG GAGACGATAT TGAAAGGAAG
AATGGATTAA CTTTTAAGAG TGCTTGTTTA GAGACGTACT ACTTTCCGAG GTTCCCGAGC GTGAAAGGGG AACTTTATTG
GATAGACGTT CAATCCCATT TCAAATGGAA AAACAAACAT GCTTATAAGT CAACCAAGTC ACCCATTTCT TATTATTTTG
TAACTTAGCT TGAATTTAAA TGATGATCGT TTACCATCAA TTGTGCAAGA TACCTTGTGA TTGTGGCATT TAACCACATG
CACCTTGAAA AGTACTTCGC ACAGTTTTTA GTCCAGCACT TAGATTCTCA GTGAAAAGTC ACACTATTCT AGTCAGTCTT
GTGCGAATTA AGTTATAATT TTTGGCAAAA TTACCTTCTC TTTCAAAGGA AAGAAAACAA CTGAGATTTT TTTTTCTCTC
AATCAAACAT ATCTAGAGCT AGAAGGACCG GCTGCAAACT AGGTATTATA ATAGACCAGA CTTTGTGCCT ATTTTCATTG
TTCTTGGTCT AGGGCTAACT GTATATGCTA AATAAGTGAA GCATTAGTTA AACACCAGGT TTGATGAATA GTGTG

[show][hide][copy]CDS

>Vigan.02G134900.01
ATGTCGATCT TCGAGTACAA TGGGAGTGCC CTAGTGGCCA TGGTGGGGAA GAACTGCTTC GCCATTGCCA GCGATCGGAG
ACTCGGGGTT CAGCTCCAGA CTATCGCCAC CGATTTCCAG AGGATTTCCA AGATCCACGA CAAGCTTTTC ATCGGTCTCT
CGGGCCTCGC CACCGACGCT CAGACGCTCT ACCAGCGCCT CGTTTTCCGC CACAAATTGT ATCAGCTGCG TGAAGAGAGG
GATATGAAGC CCGAAACCTT TGCTAGCCTA GTCTCTGCTA TTCTCTACGA GAAAAGGTTT GGTCCATACT TTTGCCAACC
TGTAATTGCT GGACTAGGAG ATGAAGATAA ACCTTTCATT TGCACCATGG ATGCGATTGG AGCAAAGGAA CTTGCAAAAG
ATTTTGTTGT AGCCGGTACT GCATCTGAGT CTCTTTATGG GGCTTGCGAG TCAATGTTTA AGCCTGACAT GGAACCAGAG
GAATTGTTCG AGACTATCTC CCAAGCGCTA CAATCATCTG TCGATCGAGA TTGTTTAAGT GGCTGGGGTG GACATGTTTA
TGTTGTCACC CCAACCGAAG TAAAGGAGAC GATATTGAAA GGAAGAATGG ATTAA

[show][hide][copy]PROTEIN

>Vigan.02G134900.01
MSIFEYNGSA LVAMVGKNCF AIASDRRLGV QLQTIATDFQ RISKIHDKLF IGLSGLATDA QTLYQRLVFR HKLYQLREER
DMKPETFASL VSAILYEKRF GPYFCQPVIA GLGDEDKPFI CTMDAIGAKE LAKDFVVAGT ASESLYGACE SMFKPDMEPE
ELFETISQAL QSSVDRDCLS GWGGHVYVVT PTEVKETILK GRMD*